Tanoto Foundation Backs Landmark Research to Unlock the Code of Asian Prevalent Diseases
SINGAPORE - Media OutReach Newswire - 27 June 2025 - Tanoto Foundation today announced the funding of two transformative, Singapore-based medical research projects focused on diseases that disproportionately affect Asian populations: prevalent and aggressive cancers, and young-onset Type 2 diabetes. The multi-year initiatives aim to generate data-driven insights that can accelerate diagnosis, improve patient outcomes, and guide public health policy.
Despite global strides in medicine, Asia continues to face rising rates of cancer and diabetes – diseases that are biologically and clinically distinct in Asian populations but remain under-researched due to a lack of region-specific data. The two research projects, from National Cancer Centre Singapore and Singapore General Hospital, will focus on filling these gaps through deep genomic studies and innovative risk-prediction models.
Imelda Tanoto, Member of the Board of Trustees, Tanoto Foundation said: 'Singapore is well-positioned to lead in medical science. It has strong research institutions and a population that reflects the diversity of Asia. By supporting researchers here who are focused on health issues that affect Asians, we hope to help drive discoveries that make a real difference to people's lives — both in Singapore and across the region.'
Tackling Asian-Prevalent Cancers
Led by Dr Jason Chan, Medical Oncologist, National Cancer Centre Singapore, the research will investigate four types of cancers with high prevalence and poor outcomes in Asia:
• Breast Cancer in Asian Women, marked by earlier onset and biological differences compared to Western populations
• T/NK-Cell Lymphomas, an aggressive blood cancer dominant in East Asians with limited treatment options
• Bile Duct Cancer (Cholangiocarcinoma), increasingly linked to environmental exposures specific to Asia
• Rare Asian Cancers, collectively neglected but accounting for up to 25% of all cases in the region
These cancers are devastating but remain poorly understood because most research has focused on Western populations,' said Dr Chan. 'By decoding their molecular and genomic landscapes in Asian patients, we want to uncover new diagnostic and therapeutic opportunities to benefit patients.'
A key feature of the project is its open-access commitment: anonymised data will be freely available to the broader research community to accelerate further discovery and collaboration.
Unmasking Diabetes Risk in Young Singaporeans
The second research project, led by Dr Daphne Gardner, Endocrinologist, Singapore General Hospital, will address the rising incidence of Type 2 diabetes in young adults, particularly prevalent in Singapore, where 1 in 5 young adults have prediabetes or diabetes, despite being of normal weight.
Unlike traditional assessments that rely heavily on BMI and family history, this project will develop a next-generation risk prediction tool by incorporating non-traditional indicators such as body fat distribution, continuous glucose monitoring, and health-seeking behaviour.
'Many young Asians with diabetes don't fit the usual risk profile. They're lean, may not have hypertension, and are therefore often overlooked by current screening models,' said Dr Gardner. 'We want to change that by identifying new risk signals and developing tools that are tailored to Singapore's population and the region.'
Findings from the study aim to inform national diabetes screening guidelines and lead to earlier interventions that can curb long-term complications.
Singapore as a Hub for Medical Research Advancement
In addition to previously supported research projects, these two initiatives reflect a growing recognition of Singapore's role in advancing precision medicine for Asian populations, driven by strong clinical infrastructure, genomic capabilities, and public-private partnerships.
Imelda Tanoto added: 'We believe precision health can change how we treat and prevent diseases. We're supporting researchers who are not only breaking new ground, but also making sure their work reaches people and communities across Asia. This is something deeply personal to us — it's about improving lives in a way that's inclusive, meaningful, and lasting.'
This announcement marks a key milestone in Tanoto Foundation's continuing effort to improve the quality of healthcare and health standards, leading to longer and better healthspans.
Hashtag: #TanotoFoundation
The issuer is solely responsible for the content of this announcement.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malay Mail
an hour ago
- Malay Mail
From threatened waters to dinner tables: Study shows six endangered species sold as fish maw in Malaysia and Singapore shops
KUALA LUMPUR, June 28 — DNA from six critically endangered and endangered fish species has been found in fish maw products sold in stores across Malaysia and Singapore, according to a new study released last week. Researchers identified DNA from the European eel and large yellow croaker — both listed as critically endangered by the International Union for Conservation of Nature (IUCN) — in samples taken from shops in both countries, The Straits Times reported today. Eleven of those samples came from the European eel, despite the European Union banning its export in 2010. 'It's not that surprising that eel maw has been sold, because you can find the eels here,' National University of Singapore (NUS) Assistant Professor Benjamin Wainwright, one of the study's authors, was quoted as saying. 'But it's interesting that the European eel is still making it here, because that should have been banned a long time ago.' The most commonly identified species was the blackspotted croaker (Protonibea diacanthus), which accounted for 58 of the 480 samples tested. The blackspotted croaker is listed as near threatened on the IUCN Red List – meaning it is at risk of becoming endangered in the near future. Four other endangered species in the fish maw samples were listed as: the cassava croaker, American eel, fourfinger threadfin, and iridescent shark. The findings were published on June 24 in the journal Conservation Letters by Wainwright and Seah Ying Giat of Universiti Malaysia Terengganu (UMT). Fish maw is made from the dried swim bladder of fish. It is considered a delicacy as well as a social status symbol for the rich that is believed to offer health benefits that is widely consumed across South-east Asia and East Asia. Between October and December 2023, the NUS-UMT researchers collected fish maw samples from Malaysian shops, followed by stores in Singapore from January to April 2024. A total of 39 different fish species were identified after the DNA extraction from 118 samples in Malaysia and 362 in Singapore. According to Wainwright, identifying species by sight is nearly impossible as the fish maw has been heavily processed. 'Fish maw has been processed, flattened, cleaned and washed. 'You can't determine what species the maw comes from without using genetic methods – so we have no idea of what species are involved in this trade in South-east Asia,' he was quoted as saying. Fresh fish maw is also served at some restaurants in Malaysia. — Picture by Ethan Lau He added that trade regulations are further complicated by broad commodity classifications. 'Commodity codes are meant to say, this is shark fin, this is shrimp, this is fish maw – but at the moment, all these products are lumped together and imported as dried fish goods.' Chester Gan, marine lead at Singapore's World Wide Fund for Nature urged consumers and companies to consider sustainability. 'Given that fish maw may originate from fisheries with little data, endangered species, or unsustainable fishing practices that harm vulnerable marine life, we urge both consumers and businesses to consider more sustainable alternatives,' he told The Straits Times. Gan also called on businesses to review their supply chains to ensure responsible sourcing. Wainwright said the best approach was to avoid fish maw altogether if the species, country of origin or sustainability could not be verified. 'The hope is, as more people become aware of the damage caused by unsustainable fishing, they may turn away from products of unknown origin and towards seafood from sustainable fisheries. 'Otherwise, when a species targeted for fish maw gets fished out, it's very likely we'll turn to another species and fish that one out, and then do the same for the next ones,' he added.
The Star
7 hours ago
- The Star
When is a food considered processed versus ultra-processed?
Some processed foods may be better than their unprocessed counterparts, e.g. canned tomatoes, which are a better source of lycopene than fresh tomatoes. — TNS When I hear the term 'ultra-processed' food, my mind goes directly to what I see in most convenience stores. Sodas, energy drinks, candy bars, pastries and cheese puffs come to mind. These items contain more than their fair share of sugar and/or salt, and are sorely lacking in essential nutrients such as protein, vitamins, minerals and dietary fibre. Not everything in a package is ultra-processed, however. In fact, many healthful foods are processed, meaning they have been altered from their original state in some way. From preserving meat to home-canning fruit and vegetables, we've been processing our food for centuries, says the US-based Institute of Food Technologists. Today, everything from bread and cut vegetables to canned tuna and peanut butter are considered processed foods. Some processed food can be safer, and even more nutritious, than their natural counterpart. Canned tomatoes, for example, are a better source of lycopene – a strong antioxidant that may help lower the risk for prostate cancer in men – than fresh tomatoes. Ultra-processed foods however, are often devoid of essential nutrients, which can be a problem if they make up the bulk of one's diet. A recent US government report says 'a growing body of research associates ultra-processed foods with negative health outcomes, including in children'. So what are ultra-processed foods? Good question. As of yet, nutrition and health experts have not agreed on one standard definition. Basically, the farther away a food is from its natural state, the more processed it becomes. Here are a few examples from several sources: Fresh corn on the cob: Unprocessed Corn kernels cut off the cob, cooked and frozen: Minimally processed Canned corn: Processed Corn chips: Ultra-processed Fresh tomato: Unprocessed Canned tomatoes: Minimally processed Tomato sauce or paste: Processed Ketchup: Ultra-processed Whole grains such as wheat or oats: Minimally processed Whole grain flour, bread, tortillas, fresh or dried pasta: Processed Refined flour, instant noodles, pastries, sweetened breakfast cereals: Ultra-processed Fresh milk: Unprocessed Pasteurised milk: Minimally processed with heat to kill bacteria Cheese/plain yoghurt: Minimally processed Sweetened, flavoured yoghurt: Processed Milk chocolate, packaged yoghurt snacks: Ultra-processed Fresh whole fruit and nuts: Unprocessed Dried fruit and dried nuts and seeds: Minimally processed Fruit juice and nut butters: Processed Boxed juice drink and peanut butter cookie mix: Ultra-processed Fresh meat, poultry, fish: Unprocessed Ground meat: Minimally processed Hot dogs, sausages and other salted meats, canned fish: Processed Laboratory-grown meat, chicken nuggets: Ultra-processed Fresh olives: Unprocessed Cured olives: Minimally processed (Note: Olives must first be cured to remove bitter compounds before they are edible.) Extra virgin olive oil: Minimally processed. By the way, say food technologists, organic food ingredients are processed in the same manner as non-organic ones. Come to think of it, perhaps the best choices in a convenience store might be the nuts or the lone bananas we sometimes see at the checkout counter. – By Barbara Intermill/Tribune News Service Barbara Intermill is a registered dietitian nutritionist in the United States.
The Sun
a day ago
- The Sun
Tanoto Foundation Backs Landmark Research to Unlock the Code of Asian Prevalent Diseases
SINGAPORE - Media OutReach Newswire - 27 June 2025 - Tanoto Foundation today announced the funding of two transformative, Singapore-based medical research projects focused on diseases that disproportionately affect Asian populations: prevalent and aggressive cancers, and young-onset Type 2 diabetes. The multi-year initiatives aim to generate data-driven insights that can accelerate diagnosis, improve patient outcomes, and guide public health policy. Despite global strides in medicine, Asia continues to face rising rates of cancer and diabetes – diseases that are biologically and clinically distinct in Asian populations but remain under-researched due to a lack of region-specific data. The two research projects, from National Cancer Centre Singapore and Singapore General Hospital, will focus on filling these gaps through deep genomic studies and innovative risk-prediction models. Imelda Tanoto, Member of the Board of Trustees, Tanoto Foundation said: 'Singapore is well-positioned to lead in medical science. It has strong research institutions and a population that reflects the diversity of Asia. By supporting researchers here who are focused on health issues that affect Asians, we hope to help drive discoveries that make a real difference to people's lives — both in Singapore and across the region.' Tackling Asian-Prevalent Cancers Led by Dr Jason Chan, Medical Oncologist, National Cancer Centre Singapore, the research will investigate four types of cancers with high prevalence and poor outcomes in Asia: • Breast Cancer in Asian Women, marked by earlier onset and biological differences compared to Western populations • T/NK-Cell Lymphomas, an aggressive blood cancer dominant in East Asians with limited treatment options • Bile Duct Cancer (Cholangiocarcinoma), increasingly linked to environmental exposures specific to Asia • Rare Asian Cancers, collectively neglected but accounting for up to 25% of all cases in the region These cancers are devastating but remain poorly understood because most research has focused on Western populations,' said Dr Chan. 'By decoding their molecular and genomic landscapes in Asian patients, we want to uncover new diagnostic and therapeutic opportunities to benefit patients.' A key feature of the project is its open-access commitment: anonymised data will be freely available to the broader research community to accelerate further discovery and collaboration. Unmasking Diabetes Risk in Young Singaporeans The second research project, led by Dr Daphne Gardner, Endocrinologist, Singapore General Hospital, will address the rising incidence of Type 2 diabetes in young adults, particularly prevalent in Singapore, where 1 in 5 young adults have prediabetes or diabetes, despite being of normal weight. Unlike traditional assessments that rely heavily on BMI and family history, this project will develop a next-generation risk prediction tool by incorporating non-traditional indicators such as body fat distribution, continuous glucose monitoring, and health-seeking behaviour. 'Many young Asians with diabetes don't fit the usual risk profile. They're lean, may not have hypertension, and are therefore often overlooked by current screening models,' said Dr Gardner. 'We want to change that by identifying new risk signals and developing tools that are tailored to Singapore's population and the region.' Findings from the study aim to inform national diabetes screening guidelines and lead to earlier interventions that can curb long-term complications. Singapore as a Hub for Medical Research Advancement In addition to previously supported research projects, these two initiatives reflect a growing recognition of Singapore's role in advancing precision medicine for Asian populations, driven by strong clinical infrastructure, genomic capabilities, and public-private partnerships. Imelda Tanoto added: 'We believe precision health can change how we treat and prevent diseases. We're supporting researchers who are not only breaking new ground, but also making sure their work reaches people and communities across Asia. This is something deeply personal to us — it's about improving lives in a way that's inclusive, meaningful, and lasting.' This announcement marks a key milestone in Tanoto Foundation's continuing effort to improve the quality of healthcare and health standards, leading to longer and better healthspans. Hashtag: #TanotoFoundation The issuer is solely responsible for the content of this announcement.
